11/2/2025 | 18:10 | APS | Biotech Rips On Topline Analysis |
11/2/2025 | 15:28 | EDGAR2 | Form 8-K - Current report |
11/2/2025 | 11:46 | GLOBE | Lipella Pharmaceuticals Reports Positive Topline Phase 2a.. |
10/2/2025 | 23:35 | EDGAR2 | Form SCHEDULE 13D/A - General Statement of Acquisition of.. |
06/2/2025 | 12:00 | GLOBE | Lipella Pharmaceuticals Granted FDA Approval for Expanded.. |
18/1/2025 | 02:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16/1/2025 | 12:51 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13/1/2025 | 14:42 | EDGAR2 | Form 8-K - Current report |
10/1/2025 | 19:24 | GLOBE | Spartan Capital Securities, LLC Serves as Sole Placement.. |
07/1/2025 | 23:25 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
06/1/2025 | 23:25 | EDGAR2 | Form 8-K - Current report |
04/1/2025 | 03:25 | EDGAR2 | Form SCHEDULE 13D/A - General Statement of Acquisition of.. |
04/1/2025 | 03:22 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
30/12/2024 | 22:11 | EDGAR2 | Form 8-K - Current report |
28/12/2024 | 03:31 | EDGAR2 | Form SCHEDULE 13D/A - General Statement of Acquisition of.. |
28/12/2024 | 03:28 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
27/12/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
20/12/2024 | 22:05 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
20/12/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
10/12/2024 | 15:29 | EDGAR2 | Form 8-K - Current report |
06/12/2024 | 22:09 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
06/12/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
03/12/2024 | 14:30 | GLOBE | Lipella Pharmaceuticals Announces Publication in CUREUS on.. |
21/11/2024 | 11:30 | GLOBE | Lipella Pharmaceuticals Announces Completion of First Cohort.. |
14/11/2024 | 23:26 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
14/11/2024 | 23:09 | EDGAR2 | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
14/11/2024 | 23:00 | EDGAR2 | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
12/11/2024 | 11:30 | GLOBE | Lipella Pharmaceuticals Secures Extended Market Exclusivity.. |
07/11/2024 | 23:01 | EDGAR2 | Form 8-K - Current report |
01/11/2024 | 22:24 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
01/11/2024 | 22:00 | EDGAR2 | Form 8-K - Current report |
01/11/2024 | 21:30 | GLOBE | Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock.. |
29/10/2024 | 13:30 | GLOBE | Lipella Pharmaceuticals to Present at 2024 Spartan Capital.. |
18/10/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
17/10/2024 | 23:00 | EDGAR2 | Form SC 13D/A - General Statement of Acquisition of.. |
17/10/2024 | 23:00 | EDGAR2 | Form SC 13D/A - General Statement of Acquisition of.. |
15/10/2024 | 11:00 | GLOBE | Lipella Pharmaceuticals Announces U.S. Patent Allowance for.. |
09/10/2024 | 16:47 | GLOBE | Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare.. |
25/9/2024 | 14:30 | GLOBE | PRISM MarketView Features Q&A with Dr. Michael Chancellor:.. |
24/9/2024 | 14:00 | GLOBE | Lipella Pharmaceuticals Reports Encouraging Early.. |
11/9/2024 | 23:10 | EDGAR2 | Form 8-K - Current report |
27/8/2024 | 14:00 | GLOBE | Lipella Pharmaceuticals to Participate at H.C. Wainwright's.. |
23/8/2024 | 22:45 | EDGAR2 | Form 8-K - Current report |
22/8/2024 | 11:00 | GLOBE | Lipella Pharmaceuticals Launches Innovative Registry to.. |
21/8/2024 | 11:00 | GLOBE | Lipella Pharmaceuticals Unveils Advanced Bladder Imaging.. |
19/8/2024 | 22:05 | EDGAR2 | Form SC 13D/A - General Statement of Acquisition of.. |
13/8/2024 | 22:13 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
12/8/2024 | 14:25 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
12/8/2024 | 11:00 | GLOBE | Lipella Pharmaceuticals Doses First Two Patients in Phase 2a.. |
06/8/2024 | 22:50 | EDGAR2 | Form 8-K - Current report |